Blueprint Medicines Corporation
Símbolo: 0HOJ.L
LSE
91.075
USDPreço de mercado atual
-23.2788
Rácio P/E
-0.1299
Rácio PEG
5.58B
Capitalização da MRK
- 0.00%
Rendimento DIV
Blueprint Medicines Corporation (0HOJ-L) Demonstrações financeiras
Balanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 710.6 | 945 | 477.1 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 639.4 | 825.3 | 267.2 | |||||||||||
balance-sheet.row.net-receivables | 0 | 43.2 | 36.9 | 37 | |||||||||||
balance-sheet.row.inventory | 0 | 21.2 | 29.7 | 21.8 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 33.4 | 35 | 18.1 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 808.4 | 1046.7 | 554 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 115.7 | 115.2 | 120.9 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 94.6 | 166.5 | 562.7 | |||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 30.6 | 21.6 | 14.6 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 240.9 | 303.3 | 698.2 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 0 | 1049.3 | 1349.9 | 1252.2 | |||||||||||
balance-sheet.row.account-payables | 0 | 4.7 | 2.7 | 8.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 81.4 | 44.7 | 8.1 | |||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 611 | 535.3 | 103.3 | |||||||||||
Deferred Revenue Non Current | 0 | 4.8 | 13.6 | 25.1 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 128 | 131.1 | 121.8 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 703.7 | 652 | 131.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 81.8 | 92.8 | 103.3 | |||||||||||
balance-sheet.row.total-liab | 0 | 918.6 | 835.2 | 281.5 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | -2339.9 | -1833 | -1275.4 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -3.5 | -10.4 | -4.1 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2474 | 2358 | 2250.3 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 130.6 | 514.7 | 970.7 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1049.3 | 1349.9 | 1252.2 | |||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-equity | 0 | 130.6 | 514.7 | 970.7 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 733.9 | 991.7 | 829.9 | |||||||||||
balance-sheet.row.total-debt | 0 | 774.1 | 672.8 | 111.4 | |||||||||||
balance-sheet.row.net-debt | 0 | 702.8 | 553.1 | -98.5 |
Demonstração dos fluxos de caixa
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -507 | -557.5 | -644.1 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 11.7 | 20.1 | 12.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -126.1 | -87.8 | -67.3 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 92.7 | 99 | 91.6 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -41.1 | -53.8 | -23.7 | |||||||||||
cash-flows.row.account-receivables | 0 | -7.7 | -2.2 | -11.8 | |||||||||||
cash-flows.row.inventory | 0 | -4.4 | -8.9 | -12.6 | |||||||||||
cash-flows.row.account-payables | 0 | 1.9 | -5.8 | 4.2 | |||||||||||
cash-flows.row.other-working-capital | 0 | -31 | -36.8 | -3.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 133.1 | 77.8 | 332 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -16.1 | -8.9 | -3.1 | |||||||||||
cash-flows.row.acquisitions-net | 0 | -290.1 | 0 | -258.2 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -766.4 | -489.7 | -655.4 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1056.5 | 349.4 | 690.8 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 290.1 | -0.3 | 0 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 274 | -149.5 | -225.9 | |||||||||||
cash-flows.row.debt-repayment | 0 | -97.9 | -553.6 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 21.3 | 8.2 | 50.7 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 424 | 50.7 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 119.2 | 561.8 | 50.7 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.2 | -0.2 | -0.9 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | -48.4 | -90.2 | -474.7 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 71.3 | 119.7 | 209.9 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 119.7 | 209.9 | 684.6 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | -436.8 | -502.3 | -298.7 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -16.1 | -8.9 | -3.1 | |||||||||||
cash-flows.row.free-cash-flow | 0 | -452.9 | -511.2 | -301.7 |
Linha de demonstração de resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 249.4 | 204 | 180.1 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 24.5 | 46.9 | 38.5 | |||||||||||
income-statement-row.row.gross-profit | 0 | 224.9 | 157.2 | 141.6 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 711.2 | 694.7 | 783.5 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 735.7 | 741.6 | 822.1 | |||||||||||
income-statement-row.row.interest-income | 0 | 32.8 | 17.7 | 2.4 | |||||||||||
income-statement-row.row.interest-expense | 0 | 51.6 | 16.8 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -19.7 | -14.8 | 0.9 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | -19.7 | -14.8 | 0.9 | |||||||||||
income-statement-row.row.interest-expense | 0 | 51.6 | 16.8 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 11.7 | 20.1 | 12.8 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | -486.3 | -537.5 | -642 | |||||||||||
income-statement-row.row.income-before-tax | 0 | -506 | -552.3 | -641.1 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 1 | 5.2 | 3 | |||||||||||
income-statement-row.row.net-income | 0 | -507 | -557.5 | -644.1 |
Perguntas frequentes
O que é Blueprint Medicines Corporation (0HOJ.L) total assets?
Blueprint Medicines Corporation (0HOJ.L) o total de activos é 1049250000.000.
Qual é a receita anual da empresa?
A receita anual é N/A.
Qual é a margem de lucro da empresa?
A margem de lucro da empresa é 0.898.
Qual é o fluxo de caixa livre da empresa?
O fluxo de caixa livre é -6.982.
Qual é a margem de lucro líquido da empresa?
A margem de lucro líquido é -1.022.
Qual é a receita total da empresa?
A receita total é -1.562.
O que é Blueprint Medicines Corporation (0HOJ.L) lucro líquido (lucro líquido)?
O lucro líquido (rendimento líquido) é -506984000.000.
Qual é a dívida total da empresa?
A dívida total é 774122000.000.
Qual é o número de despesas operacionais?
As despesas operacionais são 711196000.000.
Qual é o valor de caixa da empresa?
O dinheiro da empresa é 0.000.